ArticleNature communications2025

Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.

Magnus T Dillon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.